Cardiac-specific overexpression of SEMA3A increases the risk of death from ventricular arrhythmia due to a marked decrease in intramyocardial cardiac sympathetic nerve fibers, increased catecholamine sensitivity, and prolonged myocardial action potential duration (Fig. 2C). Here, SEMA3A is linked to Ventricular arrhythmia.